NCMM Associate Investigators
NCMM aims to continue to develop its scientific and technological capabilities by establishing strong collaborative links with key scientists and research groups across Norway, thus facilitating translational networking.
NCMM’s Associate Investigators are drawn from a group of outstanding scientists who are based in Norway, with expertise compatible with NCMM’s research areas and who are interested in collaborating with NCMM. Associate Investigators contribute their expertise in molecular and translational medicine, and support newly recruited young NCMM Group Leaders and early-stage Associate Investigators through mentoring activities.
NCMM Associate Investigators continue to work at their host institutions, but are credited an affiliation to NCMM and the Nordic EMBL Partnership for molecular medicine and are eligible to apply for seed-funding grants for collaborative projects with NCMM group leaders. In 2019, 4 million NOK seed money funding was made available for 11 new collaborative projects with NCMM group leaders.
NCMM has now entered its third 5-year period (2020-2024) which has resulted in evaluation of the Associate Investigator network. A new call is also planned for spring 2020. The evaluation of the network will allow new Associate Investigators to join and will also allow an update of the scientific profile. This will ensure Associate Investigators' research interests match the renewed focus of NCMM and other molecular medicine environments, as well complementing the current NCMM group leaders and the research taking place at the Centre.
All existing NCMM Associate and Young Associate Investigators were invited to apply for renewal to ensure that the research interests and focus of the Associate Investigator network remains relevant for all.
The following Associate Investigators were reappointed in April 2020:
NCMM Associate Investigators:
- Professor Ole A. Andreassen, Division of Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo
- Dr Thomas Arnesen, Department of Molecular Biology, University of Bergen and Department of Surgery, Haukeland University Hospital
- Dr Lorena Arranz, Department of Medical Biology, University of Tromsø and Department of Hematology, University Hospital of Northern Norway (UNN)
- Dr Lynn Butler Odeberg, University of Tromsø (UiT) and the Karolinska Institutet
- Associate Professor Dr Simona Chera, Department of Clinical Science, University of Bergen
- Professor John-Bjarne Hansen, KG Jebsen – Thrombosis Research and Expertise Centre (TREC), Department of Clinical Medicine, UiT, The Arctic University of Norway and University Hospital of North Norway
- Dr. Nils Halberg, The Department of Biomedicine, University of Bergen
- Professor Arne Klungland, Department of Microbiology, Division of Diagnostics and Intervention, Institute of Clinical Medicine, Oslo University Hospital and Institute for Basic Medical Sciences, University of Oslo
- Professor Dirk Linke, Section for Genetics and Evolutionary Biology, University of Oslo
- Professor Karl-Johan Malmberg, Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital and Institute for Clinical Medicine, University of Oslo
- Professor Hilde Loge Nilsen, Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital (newly appointed 2017)
- Professor Ragnhild Lothe, Department of Cancer Prevention at Oslo University Hospital Department of Molecular Biosciences at the University of Oslo
- Dr. Reidar Lund, Section for Chemical Life Sciences - Biomolecules, Bio-inspired Materials and Bioanalytics, Department of Chemistry, University of Oslo
- Dr. Espen Melum, Norwegian PSC Research Center, Department of Transplantation Medicine, Oslo University Hospital
- Professor Pål R. Njølstad, KG Jebsen Centre for Diabetes Research, University of Bergen and Department of Pediatrics, Haukeland University Hospital
- Professor Johanna Olweus, KG Jebsen Center for Cancer Immunotherapy, Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital and University of Oslo
- Dr. Hege Russnes, Department of Pathology and Department of Cancer Genetics, Institute of Cancer Research, Oslo University Hospital
- Professor Anne Simonsen, Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo
- Professor Rolf Skotheim, Department of Molecular Oncology, Institute of Cancer Research, Oslo University Hospital and Institute of Informatics, University of Oslo
- Professor Kjetil Taskén, Institute for Cancer Research, Oslo University Hospital (OUH
- Associate Professor Emre Yaksi, Kavli Institute for Systems Neuroscience/Centre for Neural Computation, Norwegian University of Science and Technology (NTNU)